Why is Fluence Energy stock surging today?

Fluence Energy shares fell 2.7% in pre-market trading, continuing to decline after a recent guidance cut. The company reduced its FY26 revenue outlook to $2.9B-$3.1B and adjusted EBITDA to a loss of ~$10M, citing project delivery delays. Analysts lowered price targets, with Morgan Stanley at $15 and Roth Capital at $18. The stock trades below its 12-month average price target. Broader market weakness and the company's negative EPS and free cash flow contribute to the decline.

Fluence Energy (FLNC) missed Q2 revenue expectations by 18.8%, with shares down 10.9%. Generac (GNRC) reported a 10.6% revenue increase, beating EPS and EBITDA estimates, and shares rose 13.1%. SolarEdge (SEDG) saw a 19.6% revenue increase but missed guidance, with shares down 37%.

Fluence Energy (FLNC) reported Q3 FY2026 revenue of $649.8M, up 8% YoY but $90M below expectations due to production delays at two new contract manufacturing facilities. Order intake was $1.44B and backlog $6.4B. FY2026 revenue guidance was cut to $2.9B-$3.1B and adjusted EBITDA to -$30M to $10M. Liquidity was about $863M.

Simply Wall St reports Fluence Energy (FLNC) fell 16.3% after cutting 2026 revenue guidance to about US$2.90–US$3.10 billion from US$3.20–US$3.60 billion, citing project delays and manufacturing ramp-up issues. The company posted Q3 2026 revenue of US$649.85 million and a net loss of US$32.82 million.

The Trump administration announced a 15% tariff and minimum import prices for polysilicon derivatives, including silicon wafers, photovoltaic cells, and solar modules, to support the US solar supply chain. Analysts cited by BMO, Citi, Truist, BNP Paribas, and Barclays expect First Solar (FSLR) to benefit, with module prices potentially rising to the low to mid 40 cents per watt. Premarket: FSLR +4%, TAN +3%.

Fluence Energy (FLNC) reported a Q3 adjusted loss of 24 cents per share versus a 2-cent expected loss. Revenue from continuing operations was $600.2 million, below the $848.2 million consensus, citing production delays at new contract manufacturing facilities. Despite strong orders and record backlog, it cut FY2026 revenue guidance to $2.9 billion-$3.1 billion and adjusted EBITDA to a loss of $30 million to profit of $10 million. Shares fell about 16% premarket.